Tumor organoid models are a new tool in biomedical research, and have been recently used to explore the effects of p-ERK1/2 inhibitors on several types of cancer, including ERK inhibitor SCH772984 in hepatocellular carcinoma [38] and bladder cancer [54]. This evidence concerns the gene MAPK3 and urinary bladder carcinoma.